Vir Biotechnology Inc. (VIR)
NASDAQ · Healthcare
Vir Biotechnology Inc. Operating Income 2017–2025
Vir Biotechnology Inc. annual/quarterly operating income history and growth rate from 2017 to 2026. Operating income (EBIT) is profit from core business operations, excluding interest and income taxes. It reflects the efficiency of a company's core operations.
- Vir Biotechnology Inc. operating income for the quarter ending March 31, 2026 was -132.3 M, a 5.20% decrease year-over-year.
- Vir Biotechnology Inc. operating income for the twelve months ending March 31, 2026 was -563.7 M, a 14.17% decrease year-over-year.
- Vir Biotechnology Inc. annual operating income for 2025 was -479.3 M, a 18.37% decrease from 2024.
- Vir Biotechnology Inc. annual operating income for 2024 was -587.2 M, a 14.20% decrease from 2023.
- Vir Biotechnology Inc. annual operating income for 2023 was -684.3 M, a 182.14% decrease from 2022.
- Vir Biotechnology Inc. annual operating income for 2022 was 833.1 M.
Operating Income
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Vir Biotechnology Inc. Operating Income — FAQ
Vir Biotechnology Inc. (VIR) operating income over the last 9 years — annual and quarterly figures with year-over-year growth and charts.
What is Vir Biotechnology Inc.'s operating income?
Vir Biotechnology Inc. (VIR) reported operating income of -$479M for fiscal 2025.
Where can I see VIR's operating income history?
The chart and table above show Vir Biotechnology Inc.'s operating income by year and by quarter, including the growth rate.